Systematic Review
Published on 02 Aug 2022
Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.946307
- 4,059 views
- 6 citations
Type at least 3 characters
1,334 articles
Articles
Original Research
Published on 01 Aug 2022
Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.904969
- 2,972 views
- 3 citations
Original Research
Published on 01 Aug 2022
Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.926497
- 1,630 views
- 1 citation
Original Research
Published on 29 Jul 2022
Combination of 4-1BB and DAP10 promotes proliferation and persistence of NKG2D(bbz) CAR-T cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.893124
- 4,331 views
- 8 citations
Original Research
Published on 29 Jul 2022
Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.835603
- 4,120 views
- 8 citations
Original Research
Published on 29 Jul 2022
Umbilical cord blood: A promising source for allogeneic CAR-T cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.944248
- 5,261 views
- 24 citations
Case Report
Published on 29 Jul 2022
Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.899811
- 2,051 views
- 1 citation
Review
Published on 28 Jul 2022
Research Progress on the Microenvironment and Immunotherapy of Advanced Non-Small Cell Lung Cancer With Liver Metastases
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.893716
- 3,213 views
- 8 citations
Review
Published on 26 Jul 2022
Therapeutic targeting of VEGF and/or TGF-β to enhance anti-PD-(L)1 therapy: The evidence from clinical trials
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.905520
- 4,857 views
- 9 citations
Original Research
Published on 22 Jul 2022
PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.941666
- 2,893 views
- 1 citation
Original Research
Published on 22 Jul 2022
Cost-Utility Analysis of Camrelizumab Plus Chemotherapy Versus Chemotherapy Alone as a First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer in China
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.746526
- 2,240 views
- 8 citations
Original Research
Published on 22 Jul 2022
Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.845765
- 3,334 views
- 5 citations
Original Research
Published on 21 Jul 2022
Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.924239
- 3,911 views
- 4 citations
Editorial
Published on 20 Jul 2022
Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.970623
- 1,479 views
- 1 citation
Systematic Review
Published on 15 Jul 2022
Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.934093
- 3,878 views
- 7 citations
Review
Published on 14 Jul 2022
Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.894015
- 3,363 views
- 12 citations